Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO19801 | Euphorbia armena | Species | Euphorbiaceae | Eukaryota | UNPD* | |||
NPO19474 | Clavaria pyxidata | Species | Clavariaceae | Eukaryota | UNPD* | |||
NPO14500 | Pyrus pyraster | Species | Rosaceae | Eukaryota | UNPD* | |||
NPO8918 | Plantago depressa | Species | Plantaginaceae | Eukaryota | UNPD* | |||
NPO19673 | Galanthus nivalis | Species | Amaryllidaceae | Eukaryota | UNPD* | |||
NPO8884 | Cuscuta reflexa | Species | Convolvulaceae | Eukaryota | UNPD* | |||
NPO17557 | Hydrodictyon reticulatum | Species | Hydrodictyaceae | Eukaryota | UNPD* | |||
NPO17305 | Oenanthe phellandrium | Species | Muscicapidae | Eukaryota | UNPD* | |||
NPO19343 | Centaurea glastifolia | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO19214 | Polyscias scutellaria | Species | Araliaceae | Eukaryota | UNPD* | |||
NPO19542 | Grindelia havardii | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO10029 | Prunus dulcis | Species | Rosaceae | Eukaryota | UNPD* | |||
NPO18559 | Cucumaria okhotensis | Species | Cucumariidae | Eukaryota | UNPD* | |||
NPO19602 | Nephelium maingayi | Species | Sapindaceae | Eukaryota | UNPD* | |||
NPO15688 | Astragalus oxyphysus | Species | Fabaceae | Eukaryota | UNPD* | |||
NPO18991 | Senecio candollei | Species | Asteraceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT4430 | Individual Protein | Histidine decarboxylase | Rattus norvegicus | Inhibition | = | 0 | % | 850236 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC174020 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9091 | High Similarity | NPC235501 |
0.8806 | High Similarity | NPC25465 |
0.8759 | High Similarity | NPC237812 |
0.8759 | High Similarity | NPC18223 |
0.8705 | High Similarity | NPC185903 |
0.8571 | High Similarity | NPC286696 |
0.8358 | Intermediate Similarity | NPC15566 |
0.8276 | Intermediate Similarity | NPC327477 |
0.8235 | Intermediate Similarity | NPC180462 |
0.8214 | Intermediate Similarity | NPC126634 |
0.8112 | Intermediate Similarity | NPC210947 |
0.7746 | Intermediate Similarity | NPC470138 |
0.7655 | Intermediate Similarity | NPC470140 |
0.7619 | Intermediate Similarity | NPC470139 |
0.75 | Intermediate Similarity | NPC60537 |
0.7353 | Intermediate Similarity | NPC327613 |
0.694 | Remote Similarity | NPC111132 |
0.6838 | Remote Similarity | NPC155498 |
0.6778 | Remote Similarity | NPC313504 |
0.6688 | Remote Similarity | NPC470141 |
0.6685 | Remote Similarity | NPC201900 |
0.6644 | Remote Similarity | NPC470142 |
0.6623 | Remote Similarity | NPC243319 |
0.6541 | Remote Similarity | NPC9639 |
0.6423 | Remote Similarity | NPC326248 |
0.6423 | Remote Similarity | NPC187191 |
0.6391 | Remote Similarity | NPC124276 |
0.6375 | Remote Similarity | NPC74306 |
0.6375 | Remote Similarity | NPC315642 |
0.6259 | Remote Similarity | NPC273327 |
0.6164 | Remote Similarity | NPC313547 |
0.6139 | Remote Similarity | NPC262926 |
0.6131 | Remote Similarity | NPC473646 |
0.6101 | Remote Similarity | NPC61198 |
0.6062 | Remote Similarity | NPC54537 |
0.604 | Remote Similarity | NPC238945 |
0.6036 | Remote Similarity | NPC282531 |
0.6 | Remote Similarity | NPC320818 |
0.5941 | Remote Similarity | NPC207633 |
0.5915 | Remote Similarity | NPC186619 |
0.5914 | Remote Similarity | NPC477118 |
0.5912 | Remote Similarity | NPC324009 |
0.5886 | Remote Similarity | NPC246193 |
0.5882 | Remote Similarity | NPC477120 |
0.5875 | Remote Similarity | NPC319221 |
0.5866 | Remote Similarity | NPC290959 |
0.5848 | Remote Similarity | NPC321052 |
0.5847 | Remote Similarity | NPC477119 |
0.5843 | Remote Similarity | NPC211820 |
0.5843 | Remote Similarity | NPC318590 |
0.5843 | Remote Similarity | NPC251233 |
0.5828 | Remote Similarity | NPC30326 |
0.5819 | Remote Similarity | NPC472790 |
0.5808 | Remote Similarity | NPC274384 |
0.5808 | Remote Similarity | NPC89147 |
0.5808 | Remote Similarity | NPC177169 |
0.5808 | Remote Similarity | NPC317746 |
0.58 | Remote Similarity | NPC63433 |
0.5798 | Remote Similarity | NPC315555 |
0.5783 | Remote Similarity | NPC8590 |
0.5782 | Remote Similarity | NPC323244 |
0.5775 | Remote Similarity | NPC293163 |
0.5774 | Remote Similarity | NPC232408 |
0.5774 | Remote Similarity | NPC64705 |
0.5774 | Remote Similarity | NPC197068 |
0.5758 | Remote Similarity | NPC209525 |
0.5758 | Remote Similarity | NPC161659 |
0.5752 | Remote Similarity | NPC327579 |
0.5748 | Remote Similarity | NPC328924 |
0.5735 | Remote Similarity | NPC282247 |
0.5731 | Remote Similarity | NPC326694 |
0.5714 | Remote Similarity | NPC239737 |
0.5714 | Remote Similarity | NPC89562 |
0.5698 | Remote Similarity | NPC324484 |
0.5689 | Remote Similarity | NPC314152 |
0.5684 | Remote Similarity | NPC313514 |
0.5667 | Remote Similarity | NPC41333 |
0.5667 | Remote Similarity | NPC325906 |
0.5655 | Remote Similarity | NPC59314 |
0.564 | Remote Similarity | NPC150853 |
0.5621 | Remote Similarity | NPC21448 |
0.5621 | Remote Similarity | NPC156461 |
0.5621 | Remote Similarity | NPC107374 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC174020 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8759 | High Similarity | NPD9133 | Approved |
0.8489 | Intermediate Similarity | NPD9628 | Approved |
0.8451 | Intermediate Similarity | NPD9183 | Clinical (unspecified phase) |
0.8194 | Intermediate Similarity | NPD1451 | Approved |
0.8102 | Intermediate Similarity | NPD300 | Approved |
0.8092 | Intermediate Similarity | NPD3697 | Discontinued |
0.7959 | Intermediate Similarity | NPD9627 | Approved |
0.7931 | Intermediate Similarity | NPD875 | Clinical (unspecified phase) |
0.7548 | Intermediate Similarity | NPD1731 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD2180 | Approved |
0.7405 | Intermediate Similarity | NPD2604 | Approved |
0.7222 | Intermediate Similarity | NPD3130 | Discontinued |
0.719 | Intermediate Similarity | NPD5342 | Clinical (unspecified phase) |
0.7117 | Intermediate Similarity | NPD5768 | Phase 2 |
0.7078 | Intermediate Similarity | NPD568 | Approved |
0.7078 | Intermediate Similarity | NPD566 | Approved |
0.7078 | Intermediate Similarity | NPD567 | Approved |
0.7 | Intermediate Similarity | NPD9132 | Discontinued |
0.6941 | Remote Similarity | NPD3108 | Clinical (unspecified phase) |
0.694 | Remote Similarity | NPD8859 | Approved |
0.694 | Remote Similarity | NPD8861 | Approved |
0.694 | Remote Similarity | NPD8862 | Approved |
0.6923 | Remote Similarity | NPD3105 | Discontinued |
0.6752 | Remote Similarity | NPD3706 | Clinical (unspecified phase) |
0.6623 | Remote Similarity | NPD9081 | Clinical (unspecified phase) |
0.6622 | Remote Similarity | NPD1390 | Phase 1 |
0.6622 | Remote Similarity | NPD1389 | Clinical (unspecified phase) |
0.6622 | Remote Similarity | NPD1388 | Phase 1 |
0.6447 | Remote Similarity | NPD1807 | Clinical (unspecified phase) |
0.6375 | Remote Similarity | NPD582 | Approved |
0.6364 | Remote Similarity | NPD8271 | Discontinued |
0.6325 | Remote Similarity | NPD536 | Clinical (unspecified phase) |
0.6308 | Remote Similarity | NPD7465 | Suspended |
0.6203 | Remote Similarity | NPD576 | Discontinued |
0.6178 | Remote Similarity | NPD209 | Clinical (unspecified phase) |
0.6139 | Remote Similarity | NPD194 | Clinical (unspecified phase) |
0.6124 | Remote Similarity | NPD8119 | Discontinued |
0.6111 | Remote Similarity | NPD1430 | Approved |
0.6111 | Remote Similarity | NPD1431 | Approved |
0.6108 | Remote Similarity | NPD245 | Suspended |
0.6101 | Remote Similarity | NPD252 | Clinical (unspecified phase) |
0.609 | Remote Similarity | NPD9632 | Phase 3 |
0.6084 | Remote Similarity | NPD775 | Approved |
0.6025 | Remote Similarity | NPD1808 | Phase 1 |
0.6012 | Remote Similarity | NPD3708 | Phase 2 |
0.6011 | Remote Similarity | NPD459 | Clinical (unspecified phase) |
0.6 | Remote Similarity | NPD8641 | Approved |
0.6 | Remote Similarity | NPD515 | Phase 1 |
0.599 | Remote Similarity | NPD7834 | Approved |
0.598 | Remote Similarity | NPD8261 | Discontinued |
0.596 | Remote Similarity | NPD7981 | Discontinued |
0.5951 | Remote Similarity | NPD549 | Approved |
0.5951 | Remote Similarity | NPD1118 | Discontinued |
0.5949 | Remote Similarity | NPD3497 | Clinical (unspecified phase) |
0.5901 | Remote Similarity | NPD1121 | Approved |
0.5901 | Remote Similarity | NPD1120 | Approved |
0.5897 | Remote Similarity | NPD8629 | Discontinued |
0.5882 | Remote Similarity | NPD7980 | Clinical (unspecified phase) |
0.5862 | Remote Similarity | NPD276 | Clinical (unspecified phase) |
0.5857 | Remote Similarity | NPD8292 | Phase 2 |
0.5856 | Remote Similarity | NPD1037 | Clinical (unspecified phase) |
0.5825 | Remote Similarity | NPD1249 | Clinical (unspecified phase) |
0.5813 | Remote Similarity | NPD545 | Clinical (unspecified phase) |
0.5813 | Remote Similarity | NPD547 | Clinical (unspecified phase) |
0.5801 | Remote Similarity | NPD3347 | Clinical (unspecified phase) |
0.5789 | Remote Similarity | NPD7842 | Phase 2 |
0.5789 | Remote Similarity | NPD9606 | Approved |
0.5783 | Remote Similarity | NPD1117 | Clinical (unspecified phase) |
0.5759 | Remote Similarity | NPD870 | Clinical (unspecified phase) |
0.5752 | Remote Similarity | NPD9607 | Approved |
0.5752 | Remote Similarity | NPD307 | Approved |
0.5751 | Remote Similarity | NPD978 | Clinical (unspecified phase) |
0.575 | Remote Similarity | NPD8410 | Clinical (unspecified phase) |
0.5739 | Remote Similarity | NPD1335 | Approved |
0.5735 | Remote Similarity | NPD8075 | Discontinued |
0.5695 | Remote Similarity | NPD9374 | Approved |
0.5689 | Remote Similarity | NPD185 | Approved |
0.5686 | Remote Similarity | NPD9360 | Approved |
0.5684 | Remote Similarity | NPD7138 | Phase 2 |
0.5673 | Remote Similarity | NPD8105 | Discontinued |
0.567 | Remote Similarity | NPD8113 | Phase 2 |
0.5667 | Remote Similarity | NPD1777 | Approved |
0.5667 | Remote Similarity | NPD9373 | Approved |
0.5667 | Remote Similarity | NPD1776 | Approved |
0.5665 | Remote Similarity | NPD9605 | Phase 3 |
0.5663 | Remote Similarity | NPD193 | Suspended |
0.566 | Remote Similarity | NPD1356 | Approved |
0.566 | Remote Similarity | NPD1354 | Approved |
0.566 | Remote Similarity | NPD1355 | Clinical (unspecified phase) |
0.5655 | Remote Similarity | NPD8837 | Clinical (unspecified phase) |
0.5648 | Remote Similarity | NPD994 | Phase 2 |
0.5648 | Remote Similarity | NPD996 | Phase 2 |
0.5644 | Remote Similarity | NPD1119 | Phase 2 |
0.564 | Remote Similarity | NPD3085 | Phase 1 |
0.5632 | Remote Similarity | NPD1369 | Phase 2 |
0.5632 | Remote Similarity | NPD1030 | Approved |
0.5632 | Remote Similarity | NPD1029 | Clinical (unspecified phase) |
0.5632 | Remote Similarity | NPD1750 | Clinical (unspecified phase) |
0.5632 | Remote Similarity | NPD1027 | Approved |
0.5625 | Remote Similarity | NPD2624 | Phase 2 |
0.5621 | Remote Similarity | NPD249 | Approved |
0.5621 | Remote Similarity | NPD1368 | Approved |
0.5621 | Remote Similarity | NPD250 | Approved |
0.5621 | Remote Similarity | NPD166 | Approved |
0.5619 | Remote Similarity | NPD460 | Discontinued |
0.5618 | Remote Similarity | NPD516 | Clinical (unspecified phase) |
0.5607 | Remote Similarity | NPD3086 | Phase 3 |
0.56 | Remote Similarity | NPD9375 | Discontinued |
PubChem CID   | 440129 |
ChEMBL   | CHEMBL3251663 |
ZINC   |
Molecular Weight:   | 156.05 |
ALogP:   | -1.022 |
MLogP:   | 1.57 |
XLogP:   | -0.472 |
# Rotatable Bonds:   | 5 |
Polar Surface Area:   | 86.21 |
# H-Bond Aceptor:   | 5 |
# H-Bond Donor:   | 3 |
# Rings:   | 1 |
# Heavy Atoms:   | 11 |